» Articles » PMID: 17060483

Epidemiology of Nasopharyngeal Carcinoma in the United States: Improved Survival of Chinese Patients Within the Keratinizing Squamous Cell Carcinoma Histology

Overview
Journal Ann Oncol
Publisher Elsevier
Specialty Oncology
Date 2006 Oct 25
PMID 17060483
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This study examined potential survival differences among nasopharyngeal carcinoma (NPC) patients from various ethnicities in the United States.

Patients And Methods: A total of 2436 newly diagnosed NPC patients from 1992 to 2002 were analyzed from the population-based Surveillance, Epidemiology, and End Results (SEER) program. Five-year survival rate estimates and Kaplan-Meier survival curves were calculated. Cox proportional hazard ratios (HRs) were used to identify independent prognostic factors for survival.

Results: By multivariate analyses, early age of diagnosis, localized stage at presentation (versus distant, HR=0.35; P<0.0001), radiation therapy (versus none; HR=0.48; P<0.0001), undifferentiated non-keratinizing carcinoma (versus keratinizing squamous cell carcinoma; HR=0.67; P<0.0001), and Chinese ethnicity (versus Caucasian; HR=0.78; P=0.0010) were associated with improved survival. Within keratinizing squamous cell carcinoma histology, the survival advantage of Chinese patients remained even after adjustment for other prognostic factors.

Conclusions: The significant survival advantage of Chinese NPC patients within the keratinizing squamous cell carcinoma histology contributed largely to Chinese ethnicity being an independent and favorable prognostic factor for survival in NPC.

Citing Articles

Efficacy and safety of immune checkpoint inhibitors in the treatment of recurrent or metastatic nasopharyngeal carcinoma: A systematic review and meta-analysis.

Yu Z, Hong S, Yu H, Zhang X, Li Z, Chen P Chin Med J (Engl). 2024; .

PMID: 39602325 PMC: 11882294. DOI: 10.1097/CM9.0000000000003371.


TLN1: an oncogene associated with tumorigenesis and progression.

Li S, Chen A, Gui J, Zhou H, Zhu L, Mi Y Discov Oncol. 2024; 15(1):716.

PMID: 39589610 PMC: 11599537. DOI: 10.1007/s12672-024-01593-x.


Gender-Specific Survival of Nasopharyngeal Carcinoma in Endemic and Non-Endemic Areas Based on the US SEER Database and a Chinese Single-Institutional Registry.

Guo L, Dai Y, Yu Y, Wu S Clin Epidemiol. 2024; 16:769-782.

PMID: 39539417 PMC: 11559420. DOI: 10.2147/CLEP.S490023.


Nasopharyngeal carcinoma survival by histology in endemic and non-endemic areas.

Guo L, Hong J, Wang R, Chen G, Wu S Ann Med. 2024; 56(1):2425066.

PMID: 39529559 PMC: 11559018. DOI: 10.1080/07853890.2024.2425066.


Short-term OS as a surrogate endpoint for 5-year OS in nasopharyngeal carcinoma in non-endemic area.

Guan Y, Han L, Luo H, Yu B, Huang S World J Surg Oncol. 2024; 22(1):180.

PMID: 38987785 PMC: 11238357. DOI: 10.1186/s12957-024-03460-z.